<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Etiology of pericardial disease</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Etiology of pericardial disease</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Etiology of pericardial disease</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Brian D Hoit, MD</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Martin M LeWinter, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Jae K Oh, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Susan B Yeon, MD, JD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Nov 30, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>The pericardium is a fibroelastic sac made up of visceral and parietal layers separated by a (potential) space, the pericardial cavity. In healthy individuals, the pericardial cavity contains 15 to 50 mL of an ultrafiltrate of plasma. Pericardial diseases are relatively common in clinical practice and may have different presentations either as isolated disease or as a manifestation of a systemic disorder.</p><p>Although the etiology is varied and complex, the pericardium has a relatively non-specific response to these different causes with inflammation of the pericardial layers and possible increased production of pericardial fluid. Chronic inflammation with fibrosis and calcification can lead to a rigid, usually thickened and calcified pericardium, with possible progression to pericardial constriction. In some cases, the clinical presentation of acute pericardial inflammation predominates, and the presence of excess pericardial fluid is clinically unimportant. In other cases, the effusion and its clinical consequences (ie, cardiac tamponade and constrictive pericarditis) are of primary importance.</p><p>Diseases of the pericardium present clinically in one of several ways [<a href="#rid1">1,2</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Acute and recurrent pericarditis</p><p class="bulletIndent1"><span class="glyph">●</span>Pericardial effusion without major hemodynamic compromise</p><p class="bulletIndent1"><span class="glyph">●</span>Cardiac tamponade</p><p class="bulletIndent1"><span class="glyph">●</span>Constrictive pericarditis</p><p class="bulletIndent1"><span class="glyph">●</span>Effusive-constrictive pericarditis</p><p></p><p>This topic will provide a brief overview of the major causes of pericardial disease. Details of the specific pericardial disorders are discussed separately. (See  <a class="medical medical_review" href="/d/html/4940.html" rel="external">"Acute pericarditis: Clinical presentation and diagnosis"</a> and  <a class="medical medical_review" href="/d/html/4941.html" rel="external">"Pericardial effusion: Approach to diagnosis"</a> and  <a class="medical medical_review" href="/d/html/4938.html" rel="external">"Constrictive pericarditis: Diagnostic evaluation"</a>.)</p><p class="headingAnchor" id="H2"><span class="h1">CLASSIFICATION</span><span class="headingEndMark"> — </span>The etiology of pericardial diseases is best considered by using a modification of the time-honored pathologic classification of disease into inflammatory, neoplastic, vascular, congenital, and idiopathic causes  (<a class="graphic graphic_table graphicRef67851" href="/d/graphic/67851.html" rel="external">table 1</a>) [<a href="#rid3">3-5</a>]. The major causes include:</p><p class="bulletIndent1"><span class="glyph">●</span>Infectious</p><p class="bulletIndent2"><span class="glyph">•</span>Viral, including human immunodeficiency virus (HIV) and coronavirus disease 2019 (COVID-19)</p><p class="bulletIndent2"><span class="glyph">•</span>Bacterial, fungal (purulent)</p><p class="bulletIndent2"><span class="glyph">•</span>Others (Rickettsia, Chlamydia, Borrelia, Mycoplasma, Treponema, Ureaplasma, Nocardia, Tropheryma)</p><p class="bulletIndent1"><span class="glyph">●</span>Radiation</p><p class="bulletIndent1"><span class="glyph">●</span>Post cardiac injury syndrome</p><p class="bulletIndent2"><span class="glyph">•</span>Post-myocardial infarction</p><p class="bulletIndent2"><span class="glyph">•</span>Post-pericardiotomy</p><p class="bulletIndent2"><span class="glyph">•</span>Post-traumatic (including iatrogenic)</p><p class="bulletIndent1"><span class="glyph">●</span>Drugs and toxins </p><p class="bulletIndent1"><span class="glyph">●</span>Metabolic (uremia, dialysis-associated, myxedema, ovarian hyperstimulation syndrome)</p><p class="bulletIndent1"><span class="glyph">●</span>Malignancy (especially lung and breast cancer, Hodgkin lymphoma, and mesothelioma)</p><p class="bulletIndent1"><span class="glyph">●</span>Collagen vascular disease</p><p class="bulletIndent1"><span class="glyph">●</span>Idiopathic or immune-mediated [<a href="#rid6">6,7</a>]</p><p></p><p>Pericardial disease may also be a component of other, systemic disorders, including inflammatory bowel disease and familial Mediterranean fever. Aortic dissection or left ventricular free wall rupture should also be considered in patients with unstable hemodynamics and pericardial effusion.</p><p>Most of the etiologies of pericardial disease listed above can cause both "dry" pericarditis (that is, pericardial inflammation with minimal or no effusion) and pericardial effusive disease with or without inflammation.</p><p class="headingAnchor" id="H3"><span class="h1">SPECTRUM OF CLINICAL PRESENTATION</span><span class="headingEndMark"> — </span>The frequency of the specific causes of pericardial disease varies in published reports, depending in part upon geography, the patient population, and how the diagnosis was established.</p><p class="headingAnchor" id="H2638284"><span class="h2">Acute pericarditis</span><span class="headingEndMark"> — </span>Acute pericarditis can present in a variety of ways, depending on the underlying etiology  (<a class="graphic graphic_table graphicRef60949" href="/d/graphic/60949.html" rel="external">table 2</a>) [<a href="#rid8">8-12</a>]. Patients with an infectious etiology may present with signs and symptoms of systemic infection such as fever and leukocytosis. Viral etiologies in particular may be preceded by "flu-like" respiratory or gastrointestinal symptoms. Patients with a known autoimmune disorder or malignancy may present with signs or symptoms specific to their underlying disorder.</p><p>The major clinical manifestations of acute pericarditis include [<a href="#rid2">2,5,13</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Chest pain – Typically sharp and pleuritic, improved by sitting up and leaning forward.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Pericardial friction rub – A superficial scratchy or squeaking sound best heard with the diaphragm of the stethoscope over the left sternal border.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Electrocardiogram (ECG) changes – New widespread ST elevation or PR depression.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Pericardial effusion.</p><p></p><p>At least two of these features should be present to make the diagnosis. (See  <a class="medical medical_review" href="/d/html/4940.html" rel="external">"Acute pericarditis: Clinical presentation and diagnosis", section on 'Clinical features'</a>.)</p><p class="headingAnchor" id="H4"><span class="h2">Pericardial effusion</span><span class="headingEndMark"> — </span>Patients with a hemodynamically significant pericardial effusion leading to cardiac tamponade usually present with signs and symptoms related to impaired cardiac function (ie, dyspnea, elevated jugular venous pressure, hypotension and impaired perfusion). However, in the absence of cardiac tamponade, most patients with a pericardial effusion have no symptoms specific to the effusion, but may have symptoms related to the underlying cause (eg, fever in the setting of pericarditis, etc). Thus, pericardial effusions are often discovered incidentally during evaluation of other cardiopulmonary diseases, and are typically diagnosed by echocardiography. (See  <a class="medical medical_review" href="/d/html/4941.html" rel="external">"Pericardial effusion: Approach to diagnosis"</a> and  <a class="medical medical_review" href="/d/html/4921.html" rel="external">"Cardiac tamponade"</a>.)</p><p>Several case series have reported estimates of the frequency of specific causes of pericardial effusion  (<a class="graphic graphic_table graphicRef78847" href="/d/graphic/78847.html" rel="external">table 3</a>) [<a href="#rid14">14-18</a>]. Not surprisingly, the distribution of causes varies with demographics and diagnostic strategies. For example, polymerase chain reaction (PCR) is more sensitive for the detection of infection than cultures; therefore, a study employing PCR will likely have an increased incidence of infectious etiologies. The increased incidence of iatrogenic effusions in the more contemporary series  (<a class="graphic graphic_table graphicRef78847" href="/d/graphic/78847.html" rel="external">table 3</a>) reflects the growing number of invasive cardiovascular procedures being performed.</p><p class="headingAnchor" id="H5"><span class="h3">Hemorrhagic pericardial effusion</span><span class="headingEndMark"> — </span>Patients with hemorrhagic pericardial effusions have a different distribution of causes than those with serous effusions, although there is considerable overlap. Malignancy should always be considered, and tuberculosis is a frequent cause of hemorrhagic effusion in areas in which this infection is common. (See  <a class="medical medical_review" href="/d/html/4954.html" rel="external">"Pericardial disease associated with cancer: Clinical presentation and diagnosis"</a> and  <a class="medical medical_review" href="/d/html/8002.html" rel="external">"Tuberculous pericarditis"</a>.)</p><p>A series from the United States evaluated 96 cases of hemorrhagic pericardial effusion complicated by tamponade and requiring pericardiocentesis. The following causes were identified [<a href="#rid19">19</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Malignancy – 26 percent</p><p class="bulletIndent1"><span class="glyph">●</span>Percutaneous interventional procedures – 18 percent</p><p class="bulletIndent1"><span class="glyph">●</span>Post-pericardiotomy syndrome – 13 percent</p><p class="bulletIndent1"><span class="glyph">●</span>Complications of myocardial infarction (free wall rupture, thrombolysis) – 11 percent</p><p class="bulletIndent1"><span class="glyph">●</span>Idiopathic – 10 percent</p><p class="bulletIndent1"><span class="glyph">●</span>Other causes (including uremia, aortic dissection, trauma, etc) – 22 percent</p><p></p><p>Because efforts to diagnose viral infections were not undertaken, the frequency of hemorrhagic effusions in viral pericarditis was not addressed.</p><p class="headingAnchor" id="H6"><span class="h3">Symptomatic pericardial effusion</span><span class="headingEndMark"> — </span>The distribution of causes of large symptomatic pericardial effusions was evaluated in a review of 173 consecutive patients undergoing pericardiocentesis [<a href="#rid20">20</a>]. Symptomatic was defined as cardiorespiratory symptoms (eg, dyspnea), signs (eg, tachycardia), echocardiographic features of right heart compromise, or if pericardiocentesis was deemed therapeutically indicated by the clinician.</p><p>The following distribution of causes was noted:</p><p class="bulletIndent1"><span class="glyph">●</span>Malignancy – 33 percent (45 of the 58 patients previously known to have a malignancy)</p><p class="bulletIndent1"><span class="glyph">●</span>Chronic-idiopathic – 14 percent</p><p class="bulletIndent1"><span class="glyph">●</span>Acute pericarditis – 12 percent</p><p class="bulletIndent1"><span class="glyph">●</span>Trauma – 12 percent</p><p class="bulletIndent1"><span class="glyph">●</span>Uremia – 6 percent</p><p class="bulletIndent1"><span class="glyph">●</span>Post-pericardiotomy – 5 percent</p><p class="bulletIndent1"><span class="glyph">●</span>Indeterminate – 8 percent</p><p class="bulletIndent1"><span class="glyph">●</span>Other causes (including infection, collagen vascular disease, radiation, heart failure, etc) – 10 percent</p><p></p><p class="headingAnchor" id="H4274337299"><span class="h2">Constrictive pericarditis</span><span class="headingEndMark"> — </span>Patients with constrictive pericarditis typically present with symptoms related to fluid overload (ranging from peripheral edema to anasarca), symptoms related to diminished cardiac output in response to exertion (eg, fatigability and dyspnea on exertion) or at rest, or both. Patients typically present months to years after an initial insult involving the pericardium, although the majority of patients with prior involvement of the pericardium do not develop constrictive pericarditis. While the diagnosis of constrictive pericarditis is often made by echocardiography and cardiac magnetic resonance, patients commonly undergo cardiac catheterization to confirm the diagnosis. (See  <a class="medical medical_review" href="/d/html/4938.html" rel="external">"Constrictive pericarditis: Diagnostic evaluation"</a>.)</p><p class="headingAnchor" id="H2995900527"><span class="h2">Effusive constrictive pericarditis</span><span class="headingEndMark"> — </span>Pericardial pathology consistent with constrictive pericarditis with a concomitant effusion is called effusive constrictive pericarditis. Most cases of effusive constrictive pericarditis are idiopathic, reflecting the frequency of idiopathic pericardial disease in general. Effusive constrictive pericarditis is relatively uncommon (similar to constrictive pericarditis). The diagnosis of effusive constrictive pericarditis often becomes apparent following pericardiocentesis in patients initially considered to have uncomplicated cardiac tamponade. In such cases, the right atrial pressure remains elevated after removal of the pericardial effusion due to underlying constriction. In a study of 205 patients undergoing pericardiocentesis at Mayo Clinic, effusive constrictive pericarditis was diagnosed in 33 (16 percent); the etiology was procedure-related hemopericardium in 11 (33 percent), idiopathic in 9 (27 percent), post-cardiac surgery in 6 (18 percent), post-viral pericarditis in 3 (9 percent), malignancy in 2 (6 percent), and other in 2 (6 percent) [<a href="#rid21">21</a>]. (See  <a class="medical medical_review" href="/d/html/4938.html" rel="external">"Constrictive pericarditis: Diagnostic evaluation"</a>.)</p><p class="headingAnchor" id="H2461144556"><span class="h1">ESTABLISHING THE DIAGNOSIS</span><span class="headingEndMark"> — </span>The yield of a full diagnostic evaluation is much lower in patients presenting primarily with acute pericarditis without a significant pericardial effusion than in those who present with a significant pericardial effusion. In two series with a total of 331 patients with acute pericarditis, a specific diagnosis was established in only 16 percent [<a href="#rid8">8,9</a>]. The most common were neoplasia (6 percent), tuberculosis (4 percent), nontuberculous infection (2 percent), and collagen vascular disease (2 percent).</p><p>In patients with acute pericarditis in whom no cause is identified (idiopathic pericarditis), the etiology is frequently presumed to be viral or immune-mediated [<a href="#rid6">6,7</a>], but evidence for this is usually not sought because of the expense involved, the inaccessibility of pericardial tissue/fluid, the time delay and inaccuracy of viral titers, and the general lack of impact of this information on management. It is possible that many cases in which an identifiable cause exists are labeled "idiopathic pericarditis" as a result of an insufficiently rigorous diagnostic evaluation. However, a complex and exhaustive testing strategy is typically not justified in such patients given the limited implications for clinical management. One clinically important exception to this approach is the absence of a prompt and adequate response to standard treatment, in which case more aggressive efforts at establishing a diagnosis are warranted.</p><p>Epicardial/pericardial biopsy using pericardioscopy has improved the diagnostic yield, but it is not widely available. It may be useful for relapsing cardiac tamponade, suspected bacterial or neoplastic pericarditis, worsening pericarditis without a definitive diagnosis despite medical treatment, and symptomatic moderate to large pericardial effusions [<a href="#rid2">2,22</a>].</p><p class="headingAnchor" id="H8"><span class="h1">INFECTION</span><span class="headingEndMark"> — </span>Virtually any infectious organism can infect the pericardium  (<a class="graphic graphic_table graphicRef67851" href="/d/graphic/67851.html" rel="external">table 1</a>). While most infectious causes of pericardial disease result in a typical acute presentation (ie, acute pericarditis or pericardial effusion), some organisms, especially bacteria and fungi, can cause a purulent inflammatory exudate. (See  <a class="medical medical_review" href="/d/html/2128.html" rel="external">"Purulent pericarditis"</a>.)</p><p>The frequency of specific pathogens in infectious pericardial disease has been changing in recent decades and continues to vary with geography. Tuberculous pericarditis has become much less common in developed countries, while HIV infection remains an important cause of pericardial disease in the developing world.</p><p>The clinical manifestations are often confined to the pericardium, as in viral pericarditis, but extrapericardial infection may be a prominent component of the clinical picture, as in pneumonia or empyema with associated pericardial involvement. In some cases, particularly with tuberculous or fungal infection, an infectious pericarditis can result in chronic constrictive pericarditis. (See  <a class="medical medical_review" href="/d/html/8002.html" rel="external">"Tuberculous pericarditis"</a> and  <a class="medical medical_review" href="/d/html/4938.html" rel="external">"Constrictive pericarditis: Diagnostic evaluation"</a>.)</p><p class="headingAnchor" id="H9"><span class="h2">Viral</span><span class="headingEndMark"> — </span>Though the most common viral infections causing pericarditis are reported to be coxsackievirus (types A and B) and echovirus, most of these data come from children diagnosed by serologic testing in the 1960s. More recent data suggest that adult patients are more commonly infected with cytomegalovirus and herpes viruses as well as HIV  (<a class="graphic graphic_table graphicRef67851" href="/d/graphic/67851.html" rel="external">table 1</a>) [<a href="#rid15">15,23</a>]. There are many viruses that have been associated with transient pericardial inflammation, which resolves without sequelae. Pericarditis, usually with myocarditis, has also been described as an infrequent complication of smallpox vaccination. (See  <a class="medical medical_review" href="/d/html/4930.html" rel="external">"Myopericarditis", section on 'Vaccinia-associated myopericarditis'</a>.)</p><p>Pericardial effusion is prevalent in patients hospitalized with COVID-19, but is infrequently attributable to pericarditis [<a href="#rid24">24</a>]; it has been associated with myocardial dysfunction and all-cause mortality. (See  <a class="medical medical_review" href="/d/html/129342.html" rel="external">"COVID-19: Cardiac manifestations in adults"</a>.)</p><p>Viral infection is less common among patients who present with pericardial effusion without pericarditis, especially if the effusion is large  (<a class="graphic graphic_table graphicRef78847" href="/d/graphic/78847.html" rel="external">table 3</a>). An exception to this may be patients with HIV, in whom pericardial effusion seems more prevalent. However, this high frequency may well be decreasing as more and more patients infected with HIV are receiving aggressive therapy. (See  <a class="medical medical_review" href="/d/html/3699.html" rel="external">"Cardiac and vascular disease in patients with HIV", section on 'Pericardial disease'</a>.)</p><p class="headingAnchor" id="H10"><span class="h2">Bacterial</span><span class="headingEndMark"> — </span>While any bacterial infection may involve the pericardium  (<a class="graphic graphic_table graphicRef67851" href="/d/graphic/67851.html" rel="external">table 1</a>), the most notable organisms include Staphylococcus, Pneumococcus, Streptococcus (rheumatic pancarditis), Haemophilus, and M. tuberculosis. Less common bacteria have the potential to invade the pericardium when the bacterial flora have been altered by prolonged antibiotic use and when the immune system is seriously compromised. (See  <a class="medical medical_review" href="/d/html/2128.html" rel="external">"Purulent pericarditis"</a> and  <a class="medical medical_review" href="/d/html/8002.html" rel="external">"Tuberculous pericarditis"</a>.)</p><p class="headingAnchor" id="H12"><span class="h2">Other infectious causes</span><span class="headingEndMark"> — </span>A variety of fungi and parasites are also known to cause pericardial disease  (<a class="graphic graphic_table graphicRef67851" href="/d/graphic/67851.html" rel="external">table 1</a>), particularly in endemic areas or in immunocompromised patients.</p><p class="headingAnchor" id="H653646588"><span class="h1">MALIGNANCY</span><span class="headingEndMark"> — </span>In two large series, malignancy was responsible for approximately 6 percent of cases of acute pericardial disease (acute pericarditis or tamponade without apparent cause) [<a href="#rid8">8,9</a>]. In addition, malignancy accounts for approximately 15 to 20 percent of moderate to large pericardial effusions  (<a class="graphic graphic_table graphicRef78847" href="/d/graphic/78847.html" rel="external">table 3</a>) [<a href="#rid14">14,15</a>]. (See  <a class="medical medical_review" href="/d/html/4954.html" rel="external">"Pericardial disease associated with cancer: Clinical presentation and diagnosis"</a>.)</p><p>Virtually any malignant tumor can metastasize to the pericardium, with the most common being lung and breast cancer and Hodgkin lymphoma. Primary tumors of the pericardium are rare and include several different types. In many cases, it is not easy to decide whether pericardial disease is a manifestation of the malignancy itself or of treatment with radiation or chemotherapy. (See  <a class="medical medical_review" href="/d/html/4954.html" rel="external">"Pericardial disease associated with cancer: Clinical presentation and diagnosis", section on 'Pericardial effusion'</a>.)</p><p class="headingAnchor" id="H14"><span class="h1">POST-CARDIAC INJURY SYNDROMES</span><span class="headingEndMark"> — </span>Pericarditis with or without a pericardial effusion resulting from injury of the pericardium constitutes the post-cardiac injury syndrome. The principal conditions considered under this rubric are postmyocardial infarction syndrome, post-pericardiotomy syndrome, and posttraumatic pericarditis. (See  <a class="medical medical_review" href="/d/html/4915.html" rel="external">"Post-cardiac injury syndromes"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Post-myocardial infarction syndrome</strong> – Pericardial disease, manifested as pericarditis and/or effusion, is a common event following acute myocardial infarction (MI), but has become fairly rare in the era of primary reperfusion therapy. [<a href="#rid25">25-28</a>]. An effusion that occurs early after infarction is related to the acute inflammation associated with the infarct, while immunologic mechanisms are responsible for effusions that occur several weeks to months after the infarct. The acute effusions are usually silent. (See  <a class="medical medical_review" href="/d/html/4937.html" rel="external">"Pericardial complications of myocardial infarction", section on 'Post-MI pericardial effusion'</a>.)</p><p></p><p class="bulletIndent1">Left ventricular free wall rupture can also occur after a myocardial infarction. Affected patients have a large hemorrhagic pericardial effusion and tamponade, and the diagnosis is suggested by the development of sudden, profound heart failure and shock. This syndrome is discussed separately. (See  <a class="medical medical_review" href="/d/html/63.html" rel="external">"Acute myocardial infarction: Mechanical complications", section on 'Rupture of the left ventricular free wall'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Postpericardiotomy syndrome</strong> – Postpericardiotomy syndrome occurs in up to 15 percent of patients following surgery. The presentation and clinical course of the post-pericardiotomy syndrome is comparable to that of acute pericarditis. (See  <a class="medical medical_review" href="/d/html/4915.html" rel="external">"Post-cardiac injury syndromes", section on 'Clinical features'</a>.)</p><p></p><p class="bulletIndent1">Pericardial effusion occurring within hours after cardiac surgery is more often associated with pericardial bleeding, is presumably not due to the post-cardiac injury syndrome, and is frequently associated with cardiac tamponade [<a href="#rid29">29</a>]. Post-cardiac surgery tamponade is often atypical and may be associated with left rather than right ventricular compression on echocardiography.</p><p></p><p class="bulletIndent1">Pericardial effusion also occurs in 9 to 21 percent of patients after cardiac transplantation [<a href="#rid30">30,31</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Posttraumatic pericarditis</strong> – Trauma causing pericarditis may be blunt, as with a steering wheel injury, or sharp, as with bullet or knife wounds. Iatrogenic causes include virtually all cardiac invasive diagnostic and therapeutic procedures, and rarely cardiopulmonary resuscitation. (See  <a class="medical medical_review" href="/d/html/4915.html" rel="external">"Post-cardiac injury syndromes"</a>.)</p><p></p><p class="headingAnchor" id="H2743202677"><span class="h1">RADIATION</span><span class="headingEndMark"> — </span>Prior mediastinal radiation is an important cause of pericardial disease. Most cases are secondary to radiation therapy for Hodgkin lymphoma or breast or lung cancer. Less commonly, radiation exposure occurs with thoracic radiation for other conditions (eg, esophageal cancer). However, improved shielding and dose calculation have reduced the incidence of this complication. (See  <a class="medical medical_review" href="/d/html/7062.html" rel="external">"Cardiotoxicity of radiation therapy for breast cancer and other malignancies"</a>.)</p><p>Soon after radiation, the patient may develop acute pericarditis with or without effusion [<a href="#rid32">32</a>]. Late onset of pericardial disease is common and is not necessarily preceded by acute pericarditis [<a href="#rid33">33</a>]. The late pericardial disease may consist of effusive constrictive pericarditis or classic constrictive pericarditis. (See  <a class="medical medical_review" href="/d/html/4938.html" rel="external">"Constrictive pericarditis: Diagnostic evaluation"</a>.)</p><p class="headingAnchor" id="H19"><span class="h1">DRUGS AND TOXINS</span><span class="headingEndMark"> — </span>The list of drugs and toxins that can cause pericardial disease is long  (<a class="graphic graphic_table graphicRef61171" href="/d/graphic/61171.html" rel="external">table 4</a>).</p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_general" data-topicid="9813" href="/d/drug information/9813.html" rel="external">Procainamide</a>, tocainide, <a class="drug drug_general" data-topicid="8528" href="/d/drug information/8528.html" rel="external">hydralazine</a>, <a class="drug drug_general" data-topicid="8577" href="/d/drug information/8577.html" rel="external">isoniazid</a>, <a class="drug drug_general" data-topicid="9635" href="/d/drug information/9635.html" rel="external">methyldopa</a>, and <a class="drug drug_general" data-topicid="9769" href="/d/drug information/9769.html" rel="external">phenytoin</a>, can induce a lupus-like syndrome. (See  <a class="medical medical_review" href="/d/html/4677.html" rel="external">"Drug-induced lupus"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The penicillins may cause a hypersensitivity pericarditis with eosinophilia.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_general" data-topicid="9655" href="/d/drug information/9655.html" rel="external">Minoxidil</a> (among other drugs) may produce an idiosyncratic reaction with pericardial effusion.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_general" data-topicid="9391" href="/d/drug information/9391.html" rel="external">Doxorubicin</a> and <a class="drug drug_general" data-topicid="9326" href="/d/drug information/9326.html" rel="external">daunorubicin</a> are more often associated with a cardiomyopathy, but may cause pericardial disease, as may other chemotherapy agents. Immune mediated and non-immune mediated cytotoxicity with tyrosine kinase inhibitors and immune checkpoint inhibitors have been reported to cause pericardial syndromes [<a href="#rid34">34</a>]. (See  <a class="medical medical_review" href="/d/html/2812.html" rel="external">"Cardiotoxicity of cancer chemotherapy agents other than anthracyclines, HER2-targeted agents, and fluoropyrimidines"</a>.)</p><p></p><p>Asbestos exposure, resulting in asbestosis, can also induce pericardial lesions, commonly in conjunction with pleural and parenchymal lung disease. (See  <a class="medical medical_review" href="/d/html/4307.html" rel="external">"Asbestos-related pleuropulmonary disease"</a>.)</p><p class="headingAnchor" id="H20"><span class="h1">SYSTEMIC DISORDERS</span><span class="headingEndMark"> — </span>A variety of systemic disorders have pericardial involvement:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Collagen vascular disease</strong> – A number of rheumatic diseases can involve the pericardium. Symptomatic pericarditis can occur with all of these disorders, while pericardial effusion, when present, is usually clinically silent. This is most likely to occur in systemic lupus erythematosus (SLE) and rheumatoid arthritis. In SLE, for example, the pericardium is involved in almost one-half of patients [<a href="#rid35">35</a>]. (See  <a class="medical medical_review" href="/d/html/4680.html" rel="external">"Non-coronary cardiac manifestations of systemic lupus erythematosus in adults"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Uremia and dialysis</strong> – Important causes of metabolic pericardial disease are uremia (which causes pericarditis in 6 to 10 percent of patients with advanced renal failure who are not being dialyzed) and dialysis-related pericardial effusion (occurring in approximately 13 percent of patients). Both inadequate dialysis (ie, uremic pericarditis) and fluid overload may contribute to the latter disorder [<a href="#rid36">36,37</a>]. An important clinical feature of uremic pericarditis is that the electrocardiogram does not usually show typical diffuse ST elevation, presumably because epicardial injury is uncommon [<a href="#rid37">37</a>]. The presence of ST-T abnormalities suggests some other cause for the pericarditis.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Hypothyroidism</strong> – Severe hypothyroidism, especially with classic myxedema, may be a cause of pericardial effusion but not usually pericarditis [<a href="#rid38">38</a>]. The effusion is typically slow to accumulate, which frequently results in a large (hundreds of milliliters) effusion, which is rarely hemodynamically significant. (See  <a class="medical medical_review" href="/d/html/7852.html" rel="external">"Cardiovascular effects of hypothyroidism"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Ovarian hyperstimulation syndrome</strong> – Severe ovarian hyperstimulation syndrome is a potential complication of gonadotropin therapy for the induction of ovulation. The syndrome includes the combination of underlying ovarian enlargement due to multiple ovarian cysts and an acute fluid shift out of the intravascular space that can lead to ascites and pericardial and pleural effusions. (See  <a class="medical medical_review" href="/d/html/7401.html" rel="external">"Pathogenesis, clinical manifestations, and diagnosis of ovarian hyperstimulation syndrome"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>GI disease</strong> – The pericardium can also be involved in gastrointestinal diseases. These include inflammatory bowel disease (ulcerative colitis and Crohn's disease) and Whipple's disease. (See  <a class="medical medical_review" href="/d/html/2702.html" rel="external">"Whipple's disease"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Immunoglobulin G4-related disease</strong> – This fibroinflammatory disease characterized by elevated serum levels of IgG4 and multiorgan involvement was reported as a cause of constrictive pericarditis [<a href="#rid39">39</a>].</p><p></p><p class="headingAnchor" id="H23"><span class="h1">IDIOPATHIC</span><span class="headingEndMark"> — </span>In many cases, the etiology of pericardial disease cannot be determined.</p><p class="bulletIndent1"><span class="glyph">●</span>In patients with acute pericarditis, a cause is identified in only about 16 percent, based on two large series [<a href="#rid8">8,9</a>]. The etiology in the remaining patients is frequently presumed to be viral, but evidence for this is often not sought because of the expense involved, the inaccessibility of pericardial tissue/fluid, and the time delay and inaccuracy of viral titers. (See  <a class="medical medical_review" href="/d/html/4940.html" rel="external">"Acute pericarditis: Clinical presentation and diagnosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>By comparison, a specific etiology can be established in many patients with moderate to large pericardial effusions  (<a class="graphic graphic_table graphicRef78847" href="/d/graphic/78847.html" rel="external">table 3</a>). In two series, a diagnosis of idiopathic disease was made in only 7 to 29 percent of patients [<a href="#rid14">14,15</a>]. (See  <a class="medical medical_review" href="/d/html/4941.html" rel="external">"Pericardial effusion: Approach to diagnosis"</a>.)</p><p></p><p class="headingAnchor" id="H25"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)</p><p class="bulletIndent1"><span class="glyph">●</span>Basics topics (see  <a class="medical medical_basics" href="/d/html/16976.html" rel="external">"Patient education: Pericarditis in adults (The Basics)"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Beyond the Basics topic (see  <a class="medical medical_patient" href="/d/html/3427.html" rel="external">"Patient education: Pericarditis (Beyond the Basics)"</a>)</p><p></p><p class="headingAnchor" id="H2638323"><span class="h1">SUMMARY</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Causes of pericardial disease</strong> – Pericardial disease can be a result of inflammatory, neoplastic, vascular, iatrogenic, and idiopathic causes  (<a class="graphic graphic_table graphicRef67851" href="/d/graphic/67851.html" rel="external">table 1</a>). The specific causes of pericardial disease vary depending in part upon geography, the patient population, and how the diagnosis is established. (See <a class="local">'Classification'</a> above and <a class="local">'Spectrum of clinical presentation'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Infection, most commonly viral</strong> – Though the most common viral infections causing pericarditis are reported to be coxsackievirus (types A and B) and echovirus, most of these data come from children diagnosed by serologic testing in the 1960s. More recent data suggest that adult patients are more commonly infected with cytomegalovirus and herpes viruses as well as HIV  (<a class="graphic graphic_table graphicRef67851" href="/d/graphic/67851.html" rel="external">table 1</a>). (See <a class="local">'Viral'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Malignancy</strong> – Malignancy (usually due to metastatic spread) is responsible for approximately 6 percent of cases of acute pericardial disease (acute pericarditis or tamponade without apparent cause) as well as 15 to 20 percent of moderate to large pericardial effusions. (See <a class="local">'Malignancy'</a> above and  <a class="medical medical_review" href="/d/html/4954.html" rel="external">"Pericardial disease associated with cancer: Clinical presentation and diagnosis"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Radiation</strong> – Prior mediastinal radiation is an important cause of pericardial disease, with most cases following radiation therapy for Hodgkin lymphoma, breast cancer, or lung cancer. Soon after radiation, the patient may develop acute pericarditis with or without effusion. Late onset of pericardial disease is common and may consist of effusive constrictive pericarditis, classic constrictive pericarditis, or pericardial effusion with or without tamponade. (See <a class="local">'Radiation'</a> above and  <a class="medical medical_review" href="/d/html/7062.html" rel="external">"Cardiotoxicity of radiation therapy for breast cancer and other malignancies"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Post-cardiac injury syndromes</strong> – Both pericarditis and pericardial effusion can occur following an acute myocardial infarction (MI). An effusion that occurs early after MI is related to the acute inflammation associated with the infarct, while immunologic mechanisms are responsible for effusions that occur several weeks to months after the infarct. (See <a class="local">'Post-cardiac injury syndromes'</a> above and  <a class="medical medical_review" href="/d/html/4937.html" rel="external">"Pericardial complications of myocardial infarction", section on 'Post-MI pericardial effusion'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Systemic disorders</strong> – A number of rheumatic diseases, most commonly systemic lupus erythematosus and rheumatoid arthritis, can involve the pericardium, leading to either pericardial inflammation with pleuritic pain, pericardial effusion with or without cardiac tamponade, and occasionally constrictive pericarditis. (See <a class="local">'Systemic disorders'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Evaluating the cause of acute pericarditis</strong> – In patients with acute pericarditis in whom no cause is identified (idiopathic pericarditis), the etiology is frequently presumed to be viral, and extensive evaluation for a specific diagnosis is usually not necessary. However, if a prompt and adequate response to standard treatment is not seen, more aggressive efforts at establishing a specific etiology are warranted. (See <a class="local">'Establishing the diagnosis'</a> above and  <a class="medical medical_review" href="/d/html/4940.html" rel="external">"Acute pericarditis: Clinical presentation and diagnosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Causes of pericardial effusion</strong> – The distribution of causes of pericardial effusion varies with demographics and diagnostic strategies  (<a class="graphic graphic_table graphicRef78847" href="/d/graphic/78847.html" rel="external">table 3</a>). In a patient with nontraumatic hemorrhagic pericardial effusion, malignancy and tuberculosis (particularly in an endemic area) are common. (See <a class="local">'Pericardial effusion'</a> above and <a class="local">'Hemorrhagic pericardial effusion'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Imazio M. Contemporary management of pericardial diseases. Curr Opin Cardiol 2012; 27:308.</a></li><li><a class="nounderline abstract_t">Adler Y, Charron P, Imazio M, et al. 2015 ESC Guidelines for the diagnosis and management of pericardial diseases: The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC)Endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2015; 36:2921.</a></li><li class="breakAll">Spodick DH. The Pericardium: A Comprehensive Textbook, Marcel Dekker, New York 1997. p.260.</li><li class="breakAll">Spodick DH. Pericardial disease. In: Heart Disease: A Textbook of Cardiovascular Medicine, Braunwald E, Zipes D, Libby P (Eds), Saunders, New York 2001. p.183.</li><li><a class="nounderline abstract_t">Troughton RW, Asher CR, Klein AL. Pericarditis. Lancet 2004; 363:717.</a></li><li><a class="nounderline abstract_t">Caforio AL, Brucato A, Doria A, et al. Anti-heart and anti-intercalated disk autoantibodies: evidence for autoimmunity in idiopathic recurrent acute pericarditis. Heart 2010; 96:779.</a></li><li><a class="nounderline abstract_t">Maestroni S, Di Corato PR, Cumetti D, et al. Recurrent pericarditis: autoimmune or autoinflammatory? Autoimmun Rev 2012; 12:60.</a></li><li><a class="nounderline abstract_t">Permanyer-Miralda G, Sagristá-Sauleda J, Soler-Soler J. Primary acute pericardial disease: a prospective series of 231 consecutive patients. Am J Cardiol 1985; 56:623.</a></li><li><a class="nounderline abstract_t">Zayas R, Anguita M, Torres F, et al. Incidence of specific etiology and role of methods for specific etiologic diagnosis of primary acute pericarditis. Am J Cardiol 1995; 75:378.</a></li><li><a class="nounderline abstract_t">Imazio M, Cecchi E, Demichelis B, et al. Indicators of poor prognosis of acute pericarditis. Circulation 2007; 115:2739.</a></li><li><a class="nounderline abstract_t">Reuter H, Burgess LJ, Louw VJ, Doubell AF. The management of tuberculous pericardial effusion: experience in 233 consecutive patients. Cardiovasc J S Afr 2007; 18:20.</a></li><li><a class="nounderline abstract_t">Gouriet F, Levy PY, Casalta JP, et al. Etiology of Pericarditis in a Prospective Cohort of 1162 Cases. Am J Med 2015; 128:784.e1.</a></li><li><a class="nounderline abstract_t">Imazio M, Gaita F, LeWinter M. Evaluation and Treatment of Pericarditis: A Systematic Review. JAMA 2015; 314:1498.</a></li><li><a class="nounderline abstract_t">Sagristà-Sauleda J, Mercé J, Permanyer-Miralda G, Soler-Soler J. Clinical clues to the causes of large pericardial effusions. Am J Med 2000; 109:95.</a></li><li><a class="nounderline abstract_t">Corey GR, Campbell PT, Van Trigt P, et al. Etiology of large pericardial effusions. Am J Med 1993; 95:209.</a></li><li><a class="nounderline abstract_t">Levy PY, Corey R, Berger P, et al. Etiologic diagnosis of 204 pericardial effusions. Medicine (Baltimore) 2003; 82:385.</a></li><li><a class="nounderline abstract_t">Ma W, Liu J, Zeng Y, et al. Causes of moderate to large pericardial effusion requiring pericardiocentesis in 140 Han Chinese patients. Herz 2012; 37:183.</a></li><li><a class="nounderline abstract_t">Strobbe A, Adriaenssens T, Bennett J, et al. Etiology and Long-Term Outcome of Patients Undergoing Pericardiocentesis. J Am Heart Assoc 2017; 6.</a></li><li><a class="nounderline abstract_t">Atar S, Chiu J, Forrester JS, Siegel RJ. Bloody pericardial effusion in patients with cardiac tamponade: is the cause cancerous, tuberculous, or iatrogenic in the 1990s? Chest 1999; 116:1564.</a></li><li><a class="nounderline abstract_t">Ben-Horin S, Bank I, Guetta V, Livneh A. Large symptomatic pericardial effusion as the presentation of unrecognized cancer: a study in 173 consecutive patients undergoing pericardiocentesis. Medicine (Baltimore) 2006; 85:49.</a></li><li><a class="nounderline abstract_t">Kim KH, Miranda WR, Sinak LJ, et al. Effusive-Constrictive Pericarditis After Pericardiocentesis: Incidence, Associated Findings, and Natural History. JACC Cardiovasc Imaging 2018; 11:534.</a></li><li><a class="nounderline abstract_t">Imazio M, Spodick DH, Brucato A, et al. Controversial issues in the management of pericardial diseases. Circulation 2010; 121:916.</a></li><li><a class="nounderline abstract_t">Campbell PT, Li JS, Wall TC, et al. Cytomegalovirus pericarditis: a case series and review of the literature. Am J Med Sci 1995; 309:229.</a></li><li><a class="nounderline abstract_t">Ghantous E, Szekely Y, Lichter Y, et al. Pericardial Involvement in Patients Hospitalized With COVID-19: Prevalence, Associates, and Clinical Implications. J Am Heart Assoc 2022; 11:e024363.</a></li><li><a class="nounderline abstract_t">Galve E, Garcia-Del-Castillo H, Evangelista A, et al. Pericardial effusion in the course of myocardial infarction: incidence, natural history, and clinical relevance. Circulation 1986; 73:294.</a></li><li><a class="nounderline abstract_t">Correale E, Maggioni AP, Romano S, et al. Comparison of frequency, diagnostic and prognostic significance of pericardial involvement in acute myocardial infarction treated with and without thrombolytics. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI). Am J Cardiol 1993; 71:1377.</a></li><li><a class="nounderline abstract_t">Belkin RN, Mark DB, Aronson L, et al. Pericardial effusion after intravenous recombinant tissue-type plasminogen activator for acute myocardial infarction. Am J Cardiol 1991; 67:496.</a></li><li><a class="nounderline abstract_t">Shahar A, Hod H, Barabash GM, et al. Disappearance of a syndrome: Dressler's syndrome in the era of thrombolysis. Cardiology 1994; 85:255.</a></li><li><a class="nounderline abstract_t">Stevenson LW, Child JS, Laks H, Kern L. Incidence and significance of early pericardial effusions after cardiac surgery. Am J Cardiol 1984; 54:848.</a></li><li><a class="nounderline abstract_t">Hauptman PJ, Couper GS, Aranki SF, et al. Pericardial effusions after cardiac transplantation. J Am Coll Cardiol 1994; 23:1625.</a></li><li><a class="nounderline abstract_t">Quin JA, Tauriainen MP, Huber LM, et al. Predictors of pericardial effusion after orthotopic heart transplantation. J Thorac Cardiovasc Surg 2002; 124:979.</a></li><li><a class="nounderline abstract_t">Stewart JR, Fajardo LF, Gillette SM, Constine LS. Radiation injury to the heart. Int J Radiat Oncol Biol Phys 1995; 31:1205.</a></li><li><a class="nounderline abstract_t">Applefeld MM, Wiernik PH. Cardiac disease after radiation therapy for Hodgkin's disease: analysis of 48 patients. Am J Cardiol 1983; 51:1679.</a></li><li><a class="nounderline abstract_t">Ala CK, Klein AL, Moslehi JJ. Cancer Treatment-Associated Pericardial Disease: Epidemiology, Clinical Presentation, Diagnosis, and Management. Curr Cardiol Rep 2019; 21:156.</a></li><li><a class="nounderline abstract_t">Mandell BF. Cardiovascular involvement in systemic lupus erythematosus. Semin Arthritis Rheum 1987; 17:126.</a></li><li><a class="nounderline abstract_t">Rostand SG, Rutsky EA. Pericarditis in end-stage renal disease. Cardiol Clin 1990; 8:701.</a></li><li><a class="nounderline abstract_t">Gunukula SR, Spodick DH. Pericardial disease in renal patients. Semin Nephrol 2001; 21:52.</a></li><li><a class="nounderline abstract_t">Kabadi UM, Kumar SP. Pericardial effusion in primary hypothyroidism. Am Heart J 1990; 120:1393.</a></li><li><a class="nounderline abstract_t">Sekiguchi H, Horie R, Suri RM, et al. Constrictive pericarditis caused by immunoglobulin G4-related disease. Circ Heart Fail 2012; 5:e30.</a></li></ol></div><div id="topicVersionRevision">Topic 4957 Version 28.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22450720" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Contemporary management of pericardial diseases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26320112" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : 2015 ESC Guidelines for the diagnosis and management of pericardial diseases: The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC)Endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26320112" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : 2015 ESC Guidelines for the diagnosis and management of pericardial diseases: The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC)Endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26320112" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : 2015 ESC Guidelines for the diagnosis and management of pericardial diseases: The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC)Endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15001332" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Pericarditis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20448129" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Anti-heart and anti-intercalated disk autoantibodies: evidence for autoimmunity in idiopathic recurrent acute pericarditis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22884556" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Recurrent pericarditis: autoimmune or autoinflammatory?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4050698" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Primary acute pericardial disease: a prospective series of 231 consecutive patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7856532" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Incidence of specific etiology and role of methods for specific etiologic diagnosis of primary acute pericarditis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17502574" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Indicators of poor prognosis of acute pericarditis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17392991" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : The management of tuberculous pericardial effusion: experience in 233 consecutive patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25770033" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Etiology of Pericarditis in a Prospective Cohort of 1162 Cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26461998" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Evaluation and Treatment of Pericarditis: A Systematic Review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10967149" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Clinical clues to the causes of large pericardial effusions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8356985" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Etiology of large pericardial effusions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14663288" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Etiologic diagnosis of 204 pericardial effusions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21301790" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Causes of moderate to large pericardial effusion requiring pericardiocentesis in 140 Han Chinese patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29275375" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Etiology and Long-Term Outcome of Patients Undergoing Pericardiocentesis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10593777" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Bloody pericardial effusion in patients with cardiac tamponade: is the cause cancerous, tuberculous, or iatrogenic in the 1990s?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16523053" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Large symptomatic pericardial effusion as the presentation of unrecognized cancer: a study in 173 consecutive patients undergoing pericardiocentesis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28917680" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Effusive-Constrictive Pericarditis After Pericardiocentesis: Incidence, Associated Findings, and Natural History.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20177006" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Controversial issues in the management of pericardial diseases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7900747" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Cytomegalovirus pericarditis: a case series and review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35311354" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Pericardial Involvement in Patients Hospitalized With COVID-19: Prevalence, Associates, and Clinical Implications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3943164" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Pericardial effusion in the course of myocardial infarction: incidence, natural history, and clinical relevance.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8517380" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Comparison of frequency, diagnostic and prognostic significance of pericardial involvement in acute myocardial infarction treated with and without thrombolytics. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1900139" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Pericardial effusion after intravenous recombinant tissue-type plasminogen activator for acute myocardial infarction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7987883" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Disappearance of a syndrome: Dressler's syndrome in the era of thrombolysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6486036" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Incidence and significance of early pericardial effusions after cardiac surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8195523" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Pericardial effusions after cardiac transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12407382" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Predictors of pericardial effusion after orthotopic heart transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7713783" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Radiation injury to the heart.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6858875" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Cardiac disease after radiation therapy for Hodgkin's disease: analysis of 48 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31768769" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Cancer Treatment-Associated Pericardial Disease: Epidemiology, Clinical Presentation, Diagnosis, and Management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3334284" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Cardiovascular involvement in systemic lupus erythematosus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2249224" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Pericarditis in end-stage renal disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11172559" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Pericardial disease in renal patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2248183" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Pericardial effusion in primary hypothyroidism.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22438527" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Constrictive pericarditis caused by immunoglobulin G4-related disease.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
